Histone acetylation and cancer

Current Opinion in Genetics and Development

Volumn 9, Issue 2, 1999, Pages 171-174

  Archer, Sonia Y ^a   Hodin, Richard A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; HISTONE; PROTEIN P21;

ACETYLATION; CANCER; CANCER PREVENTION; CHROMATIN STRUCTURE; COLON CANCER; DIETARY FIBER; FERMENTATION; GENE INDUCTION; PRIORITY JOURNAL; SHORT SURVEY; TRANSCRIPTION REGULATION; WHEAT;

TRITICUM AESTIVUM;

EID: 0033118943     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(99)80026-4     Document Type: Article

References (32)

1. Grunstein M: Nucleosomes: Regulators of transcription. Trends Genet 1990, 6:395-400.
2. Shaw BR, Herman TM, Kovacic RT, Beaudreau GS, Van Holde KE: Analysis of subunit organization in chicken erythrocyte chromatin. Proc Natl Acad Sci USA 1976, 73:505-509.
3. Grunstein M: Histone acetylation in chromatin structure and transcription. Nature 1997, 389:349-352. This article provides an excellent review of the role of histone acetylation in gene transcription.
4. Struhl K: Histone acetylation and transcriptional regulatory mechanisms. Genes Dev 1998, 12:599-606. An excellent recent overview of the role of histone acetylation in gene transcription and exploration of three models by which histone modification affects the transcriptional activities of specific genes.
5. Alland L, Muhle R, Hou H, Potes J, Chin L, Schreiber-Agus N, DePinho RA: Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature 1997, 387:49-55. This paper is one of the first to identify an interaction between human HDAC1 and the carboxy-terminal region of mSin3, and to show that this carboxy-terminal region is essential for Mxi1/mSin3-mediated suppression of cellular transformation.
6. Hassig CA, Fleischer TC, Billin AN, Schreiber SL, Ayer DE: Histone deacetylase activity is required for full transcriptional repression by mSin3. Cell 1997, 89:341-347. The authors show that mSin3A and HDAC1 associate in vivo and that the HDAC inhibitor, trapoxin, interferes with mSin3A-mediated transcriptional repression.
7. Brehm A, Miska EA, McCance DJ, Reid JL, Bannister AJ, Kouzarides T: Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 1998, 391:597-601. The authors show that Rb can associate with and recruit HDAC1 to the E2F-regulated cyclin E promoter. This interaction results in repression of cyclin E gene expression.
8. Magnaghi-Jaulin L, Groisman R, Naguibneva I, Robin P, Lorain S, Le Villain JP, Troalen F, Trouche D, Harel-Bellan A: Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 1998, 391:601-605. This paper, like [7••], also demonstrates a physical interaction between Rb and HDAC1. The HDAC sequence involved is an LXCXE motif similar to that used by viral transforming proteins to contact Rb. The authors suggest the Rb/HDAC1 complex is a key element in the control of cell proliferation and differentiation and is a likely target for transforming viruses.
9. Yang X-J, Ogryzko VV, Nishikawa J, Howard BH, Nakatani Y: A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 1996, 382:319-324.
10. Pasqualini JR, Mercat P, Giambiagi N: Histone acetylation decreased by estradiol in the MCF-7 human mammary cancer cell line. Breast Cancer Res Treat 1989, 14:101-105.
11. Burkitt DP: Epidemiology of cancer of the colon and rectum. Cancer 1971, 28:3-13.
12. Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Stampfer MJ, Rosner B. Speizer FE, Willet WC: Dietry fiber and the risk of colorectal cancer and adenoma in women. New Eng J Med 1999, 340:169-176.
13. Wargovich MJ, Levin B: Grist for the mill: Role of cereal fiber and calcium in prevention of colon cancer (editorial). J Natl Cancer Inst 1996, 88:67-69.
14. Zoran DL, Turner ND, Taddeo SS, Chapkin RS, Lupton JR: Wheat bran reduces tumor incidence in a rat model of colon cancer independent of effects on distal luminal butyrate concentrations. J Nutr 1997, 127:2217-2225. In a rat model of colon carcinogenesis (azoxymethane), the authors demonstrate that the less fermentable wheat bran fiber, as opposed to oats, was more protective against colon cancer development. The molar ratios of SCFAs and not the absolute butyrate concentration appeared to be most important in mediating this effect.
15. Folino M, McIntyre A, Young GP: Dietary fibers differ in their effects on large bowel epithelial proliferation and fecal fermentation-dependent events in rats. J Nutr 1995, 125:1521-1528.
16. DeCosse JJ, Miller HH, Lesser ML: Effects of wheat fiber and vitamin C and E on rectal polyps in patients with familial adenomatous polyposis. J Natl Cancer Inst 1989, 81:1290-1297.
17. Weaver GA, Krause JA, Miler TL, Wolin MJ: Short chain fatty acid distributions of enema samples from a sigmoidoscopy population: An association of high acetate and low butyrate ratios with denomatous polyps and colon cancer. Gut 1988, 29:1539-1543.
18. Kashtan H, Stern HS, Jenkins DJA, Jenkins AL, Thompson LU, Kay K, Marcon N, Minkin S, Bruce WR: Colonic fermentation and markers of colorectal-cancer risk. Am J Clin Nutr 1992, 55:723-728.
19. Clausen MR, Bonnen H, Mortensen PB: Colonic fermentation of dietary fibre to short chain fatty acids in patients with adenomatous polyps and colonic cancer. Gut 1991, 32:923-929.
20. D'Argenio G, Cosenza V, Cave MD, Iovino P, Valle ND, Lombardi G, Mazzacca G: Butyrate enemas in experimental colitis and protection against large bowel cancer in a rat model. Gastroenterology 1996, 110:1727-1734.
21. Medina V, Alfonso JJ, Alvarez-Arguelles H, Hernandez C, Gonzalez F. Sodium butyrate inhibits carcinoma development in a 1,2-dimethylhydrazine-induced rat colon cancer. J Parenter Enteral Nutr 1998, 22:14-17. This study addresses directly the effect of butyrate on development of colon cancer in a rat model and shows that butyrate decreases the incidence of colon cancers developed and that some of the tumors were of a less aggressive phenotype.
22. Velazquez OC, Jabbar A, DeMatteo RP, Rombeau JL: Butyrate inhibits seeding and growth of colorectal metastases to the liver. Surgery 1996, 120:440-448.
23. Whitehead RH, Young GP, Bhathal PS: Effects of short chain fatty acids on a new human colon carcinoma cell line (LIM1215). Gut 1986, 27:1457-1464.
24. McBain JA, Eastman A, Nobel CS, Mueller GC: Apoptotic death in adenocarcinoma cell lines induced by butyrate and other histone deacetylase inhibitors. Biochem Pharmacol 1997, 53:1357-1368.
25. Singh B, Halestrap AP, Paraskeva C: Butyrate can act as a stimulator of growth or inducer of apoptosis in human colonic epithelial cell lines depending on the presence of alternative energy sources. Carcinogenesis 1997, 18:1265-1270. This paper shows that, in the absence of glucose, low concentrations of butyrate stimulate growth of colon cancer cells; however, in the presence of glucose or at high concentrations of butyrate, apoptosis occurs.
26. SeaLy L, Chalkley R: The effect of sodium butyrate on histone modification. Cell 1978, 14:115-121.
27. Boffa LC, Lupton JR, Mariani MR, Ceppi M, Newmark HL, Scalmati A, Lipkin M: Modulation of colonic epithelial cell proliferation, histone acetylation, and luminal short chain fatty acids by variation of dietary fiber (wheat bran) in rats. Cancer Res 1992, 52:5906-5912.
28. Cuisset L, Tichonicky L, Delpech M: A protein phosphatase is involved in the inhibition of histone deacetylation by sodium butyrate. Biochem Biophys Res Commun 1998, 246:760-764. The authors show that specific serine-threonine phosphatase inhibitors blunted, to a varying degree, butyrate's effects on histone acetylation and implicate a role for a phosphatase of the PP1 type in inhibition of histone deacetylation by butyrate.
29. Barnard JA, Warwick G: Butyrate rapidly induces growth inhibition and differentiation in HT-29 cells. Cell Growth Differ 1993, 4:495-501.
30. Yoshida M, Beppu T: Reversible arrest of proliferation of rat 3Y1 fibroblasts in both the G1 and G2 phases by trichostatin A. Exp Cell Res 1988, 177:122-131.
31. WAF1 is required for butyrate-mediated growth inhibition of human colon cancer cells. Proc Natl Acad Sci USA 1998, 95:6791-6796. The authors show that p21 is induced in colon cancer cells via butyrate by a process which does not require new protein synthesis, is p53-independent, and at least partly involves histone hyperacetylation. This paper is the first to show that p21 is required for growth inhibition in colon cancer cells by butyrate.
32. Nakano K, Mizuno T, Sowa Y, Orita T, Yoshino T, Okuyama Y, Fujita T, Ohtani-Fujita N, Matsukawa Y, Tokino T et al.: Butyrate activates the WAF1/CIP1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line. J Biol Chem 1997, 272:22199-22206. This paper locates the p21 gene butyrate-response cis elements in WiDR colon cancer cells to two Sp1 sites at -82 and -69 relative to the transcriptional start site. The authors also show that a TATA element at -46 and two overlapping consensus Sp1 sites at -60 and -55 are essential for basal promoter activity.